ZhilianhaiCompany Profile: PROCEPT BioRobotics Corporation
Company and clinical focus
PROCEPT BioRobotics Corporation develops robotic technology for urology. Its portfolio includes the AquaBeam and HYDROS systems associated with Aquablation therapy. Buyers should identify the proposed platform explicitly: a company reference or an Aquablation program does not establish which generation is installed. The company website provides separate product routes.
What HYDROS is intended to do
The US FDA document for HYDROS specifies resection and removal of prostate tissue in males with lower urinary tract symptoms caused by benign prostatic hyperplasia. This is a defined indication, not a general authorization for robotic urology or prostate cancer treatment. The K240200 clearance letter is dated August 20, 2024.
Planning and robotic execution
The HYDROS product page describes imaging, assisted treatment planning and robotic tissue resection. The clinician remains responsible for the treatment plan. Procurement evaluation should therefore examine the complete imaging and operating workflow, including how the team reviews the proposed plan, confirms the treatment boundary and responds when the case requires a change.
A dated product milestone
On August 21, 2024, PROCEPT announced HYDROS clearance and described a planned US commercial release within that quarter. That announcement establishes the launch milestone; its forward-looking release schedule should not be substituted for a current delivery commitment. Product launch and regulatory clearance also do not establish comparative clinical superiority.
Hospital implementation requirements
For a practical evaluation, map the procedure from patient preparation through imaging, setup, treatment, turnover and follow-up documentation. Include the surgeon, nursing team, sterile processing, biomedical engineering and purchasing staff. Ask which components are reusable, which are single use, and which cleaning, storage and maintenance procedures apply to the exact configuration offered.
Acceptance criteria should cover training completion, equipment checks, consumable availability and support escalation. Clinical selection and patient care decisions belong to the treating team and the institution's governance process.
Evidence and purchasing boundaries
Manufacturer explanations describe the intended workflow and commercial positioning. They are not independent evidence that every hospital will achieve a particular operating time, outcome or financial return. Request the relevant instructions for use, model-specific clinical publications and a transparent explanation of which costs sit outside the equipment quotation. Evaluate utilization assumptions against the hospital's own eligible case mix.
International availability and contact
The official information request page offers a direct route to the company. An international buyer should name the destination country, proposed facility and requested system generation. Obtain written confirmation of local product registration, authorized supply arrangements, training language, service coverage and the available instrument package before comparing proposals.
Questions for a procurement brief
Which system, software version and accessories are included, and which local labeling applies?
How are installation, clinician training, preventive maintenance and urgent service scheduled?
What are the consumable ordering rules, shelf lives and contingency arrangements?
Which reference sites use the same platform and comparable workflow?
Continue with Medical and Rehabilitation Robots, Write a Robotics Buyer Brief, or Robotics RFQ.